-
Je něco špatně v tomto záznamu ?
Chronic obstructive pulmonary disease prognostic score: A new index
N. Horita, V. Koblizek, M. Plutinsky, B. Novotna, K. Hejduk, T. Kaneko
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články, validační studie
NLK
Directory of Open Access Journals
od 2001
Free Medical Journals
od 1998
Medline Complete (EBSCOhost)
od 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
PubMed
27364317
DOI
10.5507/bp.2016.030
Knihovny.cz E-zdroje
- MeSH
- chronická obstrukční plicní nemoc mortalita patofyziologie MeSH
- chůze fyziologie MeSH
- dyspnoe mortalita patofyziologie MeSH
- hemoglobiny metabolismus MeSH
- Kaplanův-Meierův odhad MeSH
- lidé středního věku MeSH
- lidé MeSH
- prognóza MeSH
- průzkumy a dotazníky MeSH
- retrospektivní studie MeSH
- senioři MeSH
- spirometrie metody MeSH
- stupeň závažnosti nemoci * MeSH
- usilovný výdechový objem fyziologie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- validační studie MeSH
BACKGROUND: The evaluation of chronic obstructive pulmonary disease (COPD) has been shifting from spirometry to focus on the patients' overall health. Despite the existence of many COPD prognostic scales, there remains a large gap for improvement, in particular a scale that incorporates the current focus on overall health. METHODS: We proposed a new prognostic scale (the COPD Prognostic Score) through discussion among the authors based on published studies. Validation was retrospective, using data from the National Emphysema Treatment Trial. RESULTS: The scores ranged from 0-16, where 16 indicated the poorest prognosis. We assigned 4 points each for forced expiratory volume in one second (%predicted), the modified Medical Research Council dyspnea scale, and age; 2 points for the hemoglobin level; and one point each for decreased activity and respiratory emergency admission in the last two years. The validation cohort included 607 patients and consisted of 388 men (73.9%) and 219 women (36.1%), mean age 67 ± 6 years and an average forced expiratory volume in one second (% predicted) of 27 ± 7%. A one-point increase in the score was associated with increased all-cause death, with a hazard ratio of 1.28 (95%CI: 1.21-1.36. P < 0.001). The areas under the receiver operating characteristic curves for two-year and five-year all-cause death for the new scale were 0.72 and 0.66, respectively. These values were higher than those given by the body mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index and age, dyspnea, airway obstruction (ADO) index. CONCLUSION: The preliminary validation for a new COPD prognostic scale: the COPD Prognostic Score was developed with promising results thus far. Above mentioned 16-point score accurately predicted 2-year and 5-year all-cause mortality among subjects who suffered from severe and very severe COPD.
Department of Pulmonology Yokohama City University Graduate School of Medicine Yokohama Japan
Institute of Biostatistics and Analyses Faculty of Medicine Masaryk University Brno Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17012966
- 003
- CZ-PrNML
- 005
- 20200212161705.0
- 007
- ta
- 008
- 170413s2016 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2016.030 $2 doi
- 035 __
- $a (PubMed)27364317
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Horita, Nobuyuki $u Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
- 245 10
- $a Chronic obstructive pulmonary disease prognostic score: A new index / $c N. Horita, V. Koblizek, M. Plutinsky, B. Novotna, K. Hejduk, T. Kaneko
- 520 9_
- $a BACKGROUND: The evaluation of chronic obstructive pulmonary disease (COPD) has been shifting from spirometry to focus on the patients' overall health. Despite the existence of many COPD prognostic scales, there remains a large gap for improvement, in particular a scale that incorporates the current focus on overall health. METHODS: We proposed a new prognostic scale (the COPD Prognostic Score) through discussion among the authors based on published studies. Validation was retrospective, using data from the National Emphysema Treatment Trial. RESULTS: The scores ranged from 0-16, where 16 indicated the poorest prognosis. We assigned 4 points each for forced expiratory volume in one second (%predicted), the modified Medical Research Council dyspnea scale, and age; 2 points for the hemoglobin level; and one point each for decreased activity and respiratory emergency admission in the last two years. The validation cohort included 607 patients and consisted of 388 men (73.9%) and 219 women (36.1%), mean age 67 ± 6 years and an average forced expiratory volume in one second (% predicted) of 27 ± 7%. A one-point increase in the score was associated with increased all-cause death, with a hazard ratio of 1.28 (95%CI: 1.21-1.36. P < 0.001). The areas under the receiver operating characteristic curves for two-year and five-year all-cause death for the new scale were 0.72 and 0.66, respectively. These values were higher than those given by the body mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index and age, dyspnea, airway obstruction (ADO) index. CONCLUSION: The preliminary validation for a new COPD prognostic scale: the COPD Prognostic Score was developed with promising results thus far. Above mentioned 16-point score accurately predicted 2-year and 5-year all-cause mortality among subjects who suffered from severe and very severe COPD.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a dyspnoe $x mortalita $x patofyziologie $7 D004417
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a usilovný výdechový objem $x fyziologie $7 D005541
- 650 _2
- $a hemoglobiny $x metabolismus $7 D006454
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a Kaplanův-Meierův odhad $7 D053208
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a chronická obstrukční plicní nemoc $x mortalita $x patofyziologie $7 D029424
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 12
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a spirometrie $x metody $7 D013147
- 650 _2
- $a průzkumy a dotazníky $7 D011795
- 650 _2
- $a chůze $x fyziologie $7 D016138
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a validační studie $7 D023361
- 700 1_
- $a Koblížek, Vladimír, $u Department of Pneumology, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital Hradec Kralove, Hradec Kralove, Czech Republic $d 1970- $7 xx0076215
- 700 1_
- $a Plutinský, Marek $u Department of Pneumology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 xx0255631
- 700 1_
- $a Novotná, Barbora $u Department of Pneumology, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital Hradec Kralove, Hradec Kralove, Czech Republic $7 xx0231471
- 700 1_
- $a Hejduk, Karel $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 xx0227632
- 700 1_
- $a Kaneko, Takeshi $u Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic $x 1213-8118 $g Roč. 160, č. 2 (2016), s. 211-218
- 910 __
- $a ABA008 $b A 1502 $c 958 $y 4 $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20200212162100 $b ABA008
- 999 __
- $a ok $b bmc $g 1205362 $s 973739
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 160 $c 2 $d 211-218 $e 20160616 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK118 $a Pubmed-20170413
